Skip to content

Propofol Sedation During Upper Endoscopy With and Without Topical Pharyngeal Anesthesia

Study of Propofol Sedation During Upper Endoscopy With and Without Topical Pharyngeal Anesthesia

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01081002
Enrollment
294
Registered
2010-03-05
Start date
2009-08-31
Completion date
2010-05-31
Last updated
2014-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conscious Sedation

Keywords

Propofol, Conscious sedation, Topical pharyngeal anesthesia, Anesthetics, Local, Gastrointestinal Endoscopy

Brief summary

It is unclear whether a topical pharyngeal anesthesia adds any benefit to the upper gastrointestinal endoscopy under a propofol sedation. We hypothesize that a topical pharyngeal anesthesia does not ease the upper gastrointestinal endoscopy under propofol sedation. The aim of this study is therefore to quantify the impact of a topical pharyngeal anesthesia to the upper gastrointestinal endoscopy in patients sedated with propofol. Patients will be randomized to receive a topical pharyngeal spray containing either an anesthetic drug (lidocaine 10%) or a placebo. Thereafter the upper endoscopy will be conducted in its standard manner.

Interventions

DRUGLidocaine 10%

3 min before the endoscopy under propofol sedation 4 puffs of lidocaine 10% will be sprayed on the pharynx as a pharyngeal anesthesia

DRUGDiluted gentian root solution

As a basis, an infusion of water (45%), ethanol (35%) and gentian root cut will be used. The gentian root infusion is approved as a natural flavor in the food industry.3 min before the endoscopy under propofol sedation 4 puffs of this gentian root infusion will be sprayed on the pharynx as a pharyngeal anesthesia

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Scheduled diagnostic upper endoscopy * Wish to be sedated * ASA class I - III * Signed informed consent

Exclusion criteria

* Emergency medical examinations * Therapeutic Endoscopy * ASA class IV * Pregnancy * Known allergy to propofol or lidocaine

Design outcomes

Primary

MeasureTime frame
Number triggered gag reflex during the intubation of the endoscopeStart of the exam until the successful intubation of the esophagus with the endoscope
Number of attempts of intubation with the endoscope through the upper esophageal sphincterStart of the exam until the successful intubation of the esophagus with the endoscope
Extent of salivation during intubationStart of the exam until the successful intubation of the esophagus with the endoscope

Secondary

MeasureTime frame
Assumption of the endoscopist if lidocaine or placebo has been usedImmediately after finishing the endoscopy
Overall assessment of the investigation by the patientImmediately after recovery of consciousness of the patient
Amount of propofol used to successfully intubate the esophagusStart of the exam until the successful intubation of the esophagus with the endoscope
Experienced problems (aspiration, bronchospasm, desaturation)From the start until the end of the exam
The impact of the individual endoscopists or registered nurses involved in the endoscopyAfter finishing the entire study
Extent of amnesia in the patientImmediately after recovery of consciousness of the patient
Total amount of propofol used during the investigationFrom the start until the end of the exam
Overall assessment of the procedure by the endoscopistImmediately after finishing the endoscopy

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026